Heart disease may increase the risk of death from COVID-19
Embargoed until:
Publicly released:
2020-03-28 02:00
Patients with heart disease may be at higher risk of death from COVID-19 according to researchers from Wuhan, China. The team retrospectively analysed data about patients with COVID-19 who were either treated and discharged, or died during hospitalisation, and found that patients with underlying heart disease were more prone to further heart injury when infected with coronavirus. The study found that further damage to the heart could result from direct damage by the virus, inflammation, and lack of oxygen. They suggest that aggressive treatment should be considered for patients at high risk of heart injury. In another paper, a JAMA case report details a case in which an otherwise healthy 53-yo contracted COVID-19, and developed heart problems a week after COVID-19 symptoms were resolved.
Journal/conference: JAMA Cardiology
Link to research (DOI): 10.1001/jamacardio.2020.1017
Organisation/s: Zhongnan Hospital of Wuhan University, China
Funder: This work was supported by the Special Project for Significant New Drug Research and Development in the Major National Science and Technology Projects of China (project 2020ZX09201007).
Media Release
From: JAMA
Cardiovascular Implications of Fatal Outcomes of Patients With COVID-19
What The Study Did: Evaluating the association of underlying cardiovascular disease and myocardial injury on fatal outcomes in patients with coronavirus disease 2019 (COVID-19).
Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19)
What The Study Did: A description of the presentation of acute myocardial inflammation in a patient with coronavirus disease 2019 (COVID-19) who recovered from influenzalike syndrome and developed fatigue and signs and symptoms of heart failure a week after upper respiratory tract symptoms
Attachments:
Note: Not all attachments are visible to the general public
-
JAMA
Web page
-
JAMA
Web page
